Literature DB >> 21741923

Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

Jessica Gierut1, Yu Zheng, Wenjun Bie, Robert E Carroll, Susan Ball-Kell, Andrea Haegebarth, Angela L Tyner.   

Abstract

BACKGROUND & AIMS: Protein tyrosine kinase 6 (PTK6) is expressed throughout the gastrointestinal tract and is a negative regulator of proliferation that promotes differentiation and DNA-damage-induced apoptosis in the small intestine. PTK6 is not expressed in normal mammary gland, but is induced in most human breast tumors. Signal transducer and activator of transcription 3 (STAT3) mediates pathogenesis of colon cancer and is a substrate of PTK6. We investigated the role of PTK6 in colon tumorigenesis.
METHODS: Ptk6+/+ and Ptk6-/- mice were injected with azoxymethane alone or in combination with dextran sodium sulfate; formation of aberrant crypt foci and colon tumors was examined. Effects of disruption of Ptk6 on proliferation, apoptosis, and STAT3 activation were examined by immunoblot and immunohistochemical analyses. Regulation of STAT3 activation was examined in the HCT116 colon cancer cell line and young adult mouse colon cells.
RESULTS: Ptk6-/- mice developed fewer azoxymethane-induced aberrant crypt foci and tumors. Induction of PTK6 increased apoptosis, proliferation, and STAT3 activation in Ptk6+/+ mice injected with azoxymethane. Disruption of Ptk6 impaired STAT3 activation following azoxymethane injection, and reduced active STAT3 levels in Ptk6-/- tumors. Stable knockdown of PTK6 reduced basal levels of active STAT3, as well as activation of STAT3 by epidermal growth factor in HCT116 cells. Disruption of Ptk6 reduced activity of STAT3 in young adult mouse colon cells.
CONCLUSIONS: PTK6 promotes STAT3 activation in the colon following injection of the carcinogen azoxymethane and regulates STAT3 activity in mouse colon tumors and in the HCT116 and young adult mouse colon cell lines. Disruption of Ptk6 decreases azoxymethane-induced colon tumorigenesis in mice.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741923      PMCID: PMC3448944          DOI: 10.1053/j.gastro.2011.06.071

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.

Authors:  Helena L Palka-Hamblin; Jessica J Gierut; Wenjun Bie; Patrick M Brauer; Yu Zheng; John M Asara; Angela L Tyner
Journal:  J Cell Sci       Date:  2009-12-21       Impact factor: 5.285

Review 2.  Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Biochim Biophys Acta       Date:  2010-02-26

3.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

Authors:  Julia Bollrath; Toby J Phesse; Vivian A von Burstin; Tracy Putoczki; Moritz Bennecke; Trudie Bateman; Tim Nebelsiek; Therese Lundgren-May; Ozge Canli; Sarah Schwitalla; Vance Matthews; Roland M Schmid; Thomas Kirchner; Melek C Arkan; Matthias Ernst; Florian R Greten
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

4.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

5.  Crypt stem cells as the cells-of-origin of intestinal cancer.

Authors:  Nick Barker; Rachel A Ridgway; Johan H van Es; Marc van de Wetering; Harry Begthel; Maaike van den Born; Esther Danenberg; Alan R Clarke; Owen J Sansom; Hans Clevers
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

6.  STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.

Authors:  Osamu Ikeda; Yuto Miyasaka; Yuichi Sekine; Akihiro Mizushima; Ryuta Muromoto; Asuka Nanbo; Akihiko Yoshimura; Tadashi Matsuda
Journal:  Biochem Biophys Res Commun       Date:  2009-04-23       Impact factor: 3.575

7.  Hsp105beta upregulates hsp70 gene expression through signal transducer and activator of transcription-3.

Authors:  Nobuyuki Yamagishi; Hajime Fujii; Youhei Saito; Takumi Hatayama
Journal:  FEBS J       Date:  2009-09-15       Impact factor: 5.542

Review 8.  Aberrant crypt foci in colon cancer epidemiology.

Authors:  Sharad Khare; Kamran Chaudhary; Marc Bissonnette; Robert Carroll
Journal:  Methods Mol Biol       Date:  2009

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis.

Authors:  Andrea Haegebarth; Ansu O Perekatt; Wenjun Bie; Jessica J Gierut; Angela L Tyner
Journal:  Gastroenterology       Date:  2009-06-06       Impact factor: 22.682

View more
  14 in total

1.  Signature of positive selection of PTK6 gene in East Asian populations: a cross talk for Helicobacter pylori invasion and gastric cancer endemicity.

Authors:  Pankaj Jha; Dongsheng Lu; Yuan Yuan; Shuhua Xu
Journal:  Mol Genet Genomics       Date:  2015-04-03       Impact factor: 3.291

2.  Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.

Authors:  Priya S Mathur; Jessica J Gierut; Grace Guzman; Hui Xie; Rosa M Xicola; Xavier Llor; Michael I Chastkofsky; Ansu O Perekatt; Angela L Tyner
Journal:  Mol Cancer Res       Date:  2016-03-16       Impact factor: 5.852

Review 3.  Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy.

Authors:  Haroon A Hussain; Amanda J Harvey
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.

Authors:  Yu Zheng; Zebin Wang; Wenjun Bie; Patrick M Brauer; Bethany E Perez White; Jing Li; Veronique Nogueira; Pradip Raychaudhuri; Nissim Hay; Debra A Tonetti; Virgilia Macias; André Kajdacsy-Balla; Angela L Tyner
Journal:  Cancer Res       Date:  2013-07-15       Impact factor: 12.701

Review 5.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

6.  Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.

Authors:  Jessica J Gierut; Priya S Mathur; Wenjun Bie; Jin Han; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2012-09-18       Impact factor: 6.261

Review 7.  Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.

Authors:  Yu Zheng; Angela L Tyner
Journal:  Eur J Clin Invest       Date:  2013-02-10       Impact factor: 4.686

8.  Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin.

Authors:  Michael I Chastkofsky; Wenjun Bie; Susan M Ball-Kell; Yu-Ying He; Angela L Tyner
Journal:  J Invest Dermatol       Date:  2015-04-30       Impact factor: 8.551

9.  Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.

Authors:  M Peng; S M Ball-Kell; A L Tyner
Journal:  Cell Death Dis       Date:  2015-08-06       Impact factor: 8.469

10.  Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models.

Authors:  M Peng; S M Ball-Kell; R R Franks; H Xie; A L Tyner
Journal:  Oncogenesis       Date:  2013-12-09       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.